The Signia Pure Charge&Go MaX 7 is the premium level of Signia's MaX platform and the most capable receiver-in-canal hearing aid Signia makes. Every MaX level runs Acoustic Intelligence - four deep neural networks analysing speech, your own voice, your surroundings and background noise at the same time. The MaX 7 runs it at full strength: RealTime Conversation Enhancement AI at its highest setting, three independent focus streams for fast group conversations, Spatial SpeechFocus for speech to your left, right or behind you, extended 12 kHz bandwidth, Auto EchoShield for echoey rooms and 48 processing channels for the most precise programming.
Signia quotes around 30 hours per charge. A full charge takes about four hours and a 30-minute top-up gives roughly six hours. The Portable Charger Pure 2.0, included with every pair, is a pocket-sized case with a built-in power bank that holds up to four further full charges.
| What's Included | Details |
|---|---|
| Warranty | 2 Years |
| Programming | Included |
| Fine-Tuning | Included x1 |
| Signia One App (Apple/Android) | Included |
| Portable Charger Pure 2.0 | Included with pairs |
| miniReceiver 3.0 | Fitted to your prescription |
| Eartips and Sleeves 3.0 | Various sizes |
| WaxGuard 3.0 Filters | Included |
| Cleaning Kit | Brush & soft cloth |
| Aftercare/Repairs | PAYG website rates |
The MaX 7 is a receiver-in-canal hearing aid worn behind the ear, so it is not an invisible device - for that, see the Signia Silk Charge&Go IX. It connects to any phone through Bluetooth Classic or LE Audio and includes a telecoil, but Auracast public audio is not live yet: the hardware is ready and Signia plans to switch it on by firmware update in the first half of 2027, delivered through the Signia One app. The older Signia app does not connect to MaX devices.
Includes Signia's tinnitus toolkit - Notch Therapy, Ocean Waves and static therapy signals - programmed alongside your hearing settings. CROS for single-sided hearing loss is not available on the MaX platform; see Signia CROS IX.